Free Trial

Vsee Health (VSEE) Competitors

Vsee Health logo
$1.34 +0.02 (+1.52%)
(As of 12/20/2024 05:31 PM ET)

VSEE vs. MRAI, PMD, TOI, BRTX, OPGN, KDLY, OTRK, MGRX, ATPC, and BGLC

Should you be buying Vsee Health stock or one of its competitors? The main competitors of Vsee Health include Marpai (MRAI), Psychemedics (PMD), Oncology Institute (TOI), BioRestorative Therapies (BRTX), OpGen (OPGN), Kindly MD (KDLY), Ontrak (OTRK), Mangoceuticals (MGRX), Agape ATP (ATPC), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry.

Vsee Health vs.

Vsee Health (NASDAQ:VSEE) and Marpai (NASDAQ:MRAI) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment.

Vsee Health has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Vsee Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Vsee HealthN/A -182.59% -58.26%
Marpai -85.70%N/A -100.23%

In the previous week, Vsee Health had 3 more articles in the media than Marpai. MarketBeat recorded 3 mentions for Vsee Health and 0 mentions for Marpai. Vsee Health's average media sentiment score of 0.21 beat Marpai's score of 0.00 indicating that Vsee Health is being referred to more favorably in the media.

Company Overall Sentiment
Vsee Health Neutral
Marpai Neutral

Vsee Health has higher earnings, but lower revenue than Marpai.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vsee Health$6.38M0.76-$4.41MN/AN/A
Marpai$37.15M0.36-$28.75M-$2.64-0.37

Marpai received 2 more outperform votes than Vsee Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Vsee HealthN/AN/A
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

1.0% of Vsee Health shares are owned by institutional investors. Comparatively, 49.8% of Marpai shares are owned by institutional investors. 6.6% of Vsee Health shares are owned by company insiders. Comparatively, 61.3% of Marpai shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Marpai has a consensus price target of $6.00, indicating a potential upside of 510.69%. Given Marpai's stronger consensus rating and higher probable upside, analysts clearly believe Marpai is more favorable than Vsee Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vsee Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Marpai beats Vsee Health on 8 of the 14 factors compared between the two stocks.

Get Vsee Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VSEE vs. The Competition

MetricVsee HealthHealth services IndustryComputer SectorNASDAQ Exchange
Market Cap$4.83M$867.07M$26.05B$9.08B
Dividend YieldN/A1.90%2.78%4.23%
P/E RatioN/A32.20238.1117.16
Price / Sales0.763.753,353.84117.04
Price / CashN/A25.1435.8237.86
Price / Book-0.392.928.144.78
Net Income-$4.41M-$5.79M$683.03M$225.60M
7 Day Performance-10.07%-4.93%0.42%-1.23%
1 Month Performance-9.46%-5.95%5.20%0.46%
1 Year PerformanceN/A218.58%22.41%15.24%

Vsee Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VSEE
Vsee Health
N/A$1.34
+1.5%
N/AN/A$4.83M$6.38M0.00N/ANews Coverage
MRAI
Marpai
N/A$1.20
-4.0%
$6.00
+400.0%
-49.6%$16.49M$34.87M-0.42150Gap Down
PMD
Psychemedics
1.4065 of 5 stars
$2.67
-1.8%
N/A-7.0%$15.73M$22.10M-5.24140Insider Trade
Gap Down
High Trading Volume
TOI
Oncology Institute
2.5251 of 5 stars
$0.20
-13.2%
$2.50
+1,170.3%
-87.6%$14.87M$378.93M-0.29660
BRTX
BioRestorative Therapies
3.455 of 5 stars
$1.46
+0.7%
$18.00
+1,132.9%
-10.9%$10.10M$150,000.00-0.917
OPGN
OpGen
N/A$1.07
-3.6%
N/A-82.7%$8.95M$3.42M0.00100Analyst Forecast
News Coverage
Gap Down
KDLY
Kindly MD
N/A$1.15
-11.5%
N/AN/A$6.87M$2.88M0.00N/AGap Down
OTRK
Ontrak
2.6135 of 5 stars
$1.60
-2.4%
$45.00
+2,712.5%
-76.7%$6.75M$11.24M-0.15250Positive News
MGRX
Mangoceuticals
1.1789 of 5 stars
$2.53
-3.1%
N/A-96.1%$6.29M$755,000.00-0.453News Coverage
Positive News
Gap Down
ATPC
Agape ATP
N/A$1.25
-12.6%
N/A-89.2%$4.99M$1.35M-1.7040Positive News
Gap Down
BGLC
BioNexus Gene Lab
N/A$0.26
flat
N/A-59.5%$4.65M$9.26M0.0030Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:VSEE) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners